The University of Southampton
University of Southampton Institutional Repository

Systematic review of anti-inflammatory effects of Chinese herbal medicines in pre-clinical and clinical studies related to mood disorders

Systematic review of anti-inflammatory effects of Chinese herbal medicines in pre-clinical and clinical studies related to mood disorders
Systematic review of anti-inflammatory effects of Chinese herbal medicines in pre-clinical and clinical studies related to mood disorders
Introduction: Inflammatory processes may be involved in the pathogenesis of mood disorders and medications with anti-inflammatory effects may provide new treatment approaches. We aimed to review current evidence regarding the anti-inflammatory effects of Chinese herbal medicines in animal ‘models’of depression and anxiety and in patients with mood disorders. Methods: Literature search performed in scientific databases including Pubmed, China National Knowledge Infrastructure (CNKI) Database, Scopus and Web of Science. Screening, data extraction and quality assessment were conducted. Primary outcome measures were pre- and post- treatment levels of peripheral inflammatory cytokines. Results: 112 studies were initially identified: after exclusion criteria were applied six studies could be included in this review (3animal studies, 3 human studies). Soyo-san reduced IL-1β-ir neurons and depression-like responses in rats. Salvianolic acid B decreased expression of IL-1β and TNFα, and increased expression of anti-inflammatory cytokines IL-10 and TGFβ. Rhizoma drynariae reduced blood levels of IL-6 and increased levels of IL10, and reduced anxiety-like and depression-like behaviors in rats. Three randomised controlled trials(including 272 participants, with treatment duration varying between 4-8 weeks) used Chinese herbal medicine as an adjunctive treatment to treatment as usual (TAU) comparing to TAU. All three trials found a significant reduction in depressive symptom severity (P <0.05). Two RCTs included Chaihu Shugan powder combined with venlafaxine and modified Chaihu Decoction combined with paroxetine: symptoms assessed by Hamilton Depression Rating Scale reduced from32.24 to 7.20 (intervention group) compared to 32.68to 12.49 (control group). After treatment serum levels of IL_2 and TNFα were significantly decreased in the two groups (P < 0. 05), significantly more so in the treatment group than in venlafaxine or paroxetine only group (P < 0.05). The third RCT investigated modified Chaihu-jia-long gu-muli-tang combined with paroxetine, and post-treatment serum levels of IL_ 1, TNFα and IL_ 6 significantly decreased in both groups (P < 0.05), significantly more so in the treatment group than in paroxetine only group (P <0.05). Conclusion: Certain Chinese herbal medicines have anti-inflammatory effects in pre-clinical and clinical studies, suggesting potential benefits in patients with depressive and anxiety disorders. Further exploratory studies and placebo-controlled randomised trials are warranted to explore potential clinical applications.
136
Hou, M
2abcef03-2073-44d4-a27e-f4fe0ef80443
Baldwin, David
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Hou, Ruihua
470bdcbc-93a9-4dad-aac5-26d455c34376
Hou, M
2abcef03-2073-44d4-a27e-f4fe0ef80443
Baldwin, David
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Hou, Ruihua
470bdcbc-93a9-4dad-aac5-26d455c34376

Hou, M, Baldwin, David and Hou, Ruihua (2018) Systematic review of anti-inflammatory effects of Chinese herbal medicines in pre-clinical and clinical studies related to mood disorders. British Association for Psychopharmacology Summer Meeting, Imperial College London, London, United Kingdom. 22 - 25 Jul 2018. p. 136 .

Record type: Conference or Workshop Item (Other)

Abstract

Introduction: Inflammatory processes may be involved in the pathogenesis of mood disorders and medications with anti-inflammatory effects may provide new treatment approaches. We aimed to review current evidence regarding the anti-inflammatory effects of Chinese herbal medicines in animal ‘models’of depression and anxiety and in patients with mood disorders. Methods: Literature search performed in scientific databases including Pubmed, China National Knowledge Infrastructure (CNKI) Database, Scopus and Web of Science. Screening, data extraction and quality assessment were conducted. Primary outcome measures were pre- and post- treatment levels of peripheral inflammatory cytokines. Results: 112 studies were initially identified: after exclusion criteria were applied six studies could be included in this review (3animal studies, 3 human studies). Soyo-san reduced IL-1β-ir neurons and depression-like responses in rats. Salvianolic acid B decreased expression of IL-1β and TNFα, and increased expression of anti-inflammatory cytokines IL-10 and TGFβ. Rhizoma drynariae reduced blood levels of IL-6 and increased levels of IL10, and reduced anxiety-like and depression-like behaviors in rats. Three randomised controlled trials(including 272 participants, with treatment duration varying between 4-8 weeks) used Chinese herbal medicine as an adjunctive treatment to treatment as usual (TAU) comparing to TAU. All three trials found a significant reduction in depressive symptom severity (P <0.05). Two RCTs included Chaihu Shugan powder combined with venlafaxine and modified Chaihu Decoction combined with paroxetine: symptoms assessed by Hamilton Depression Rating Scale reduced from32.24 to 7.20 (intervention group) compared to 32.68to 12.49 (control group). After treatment serum levels of IL_2 and TNFα were significantly decreased in the two groups (P < 0. 05), significantly more so in the treatment group than in venlafaxine or paroxetine only group (P < 0.05). The third RCT investigated modified Chaihu-jia-long gu-muli-tang combined with paroxetine, and post-treatment serum levels of IL_ 1, TNFα and IL_ 6 significantly decreased in both groups (P < 0.05), significantly more so in the treatment group than in paroxetine only group (P <0.05). Conclusion: Certain Chinese herbal medicines have anti-inflammatory effects in pre-clinical and clinical studies, suggesting potential benefits in patients with depressive and anxiety disorders. Further exploratory studies and placebo-controlled randomised trials are warranted to explore potential clinical applications.

This record has no associated files available for download.

More information

Published date: 8 August 2018
Additional Information: . Funding: This study was funded by an academic exchange award from People’s Republic of China State Administration of Foreign Experts Affairs to Shandong Mental Health Centre and University of Southampton
Venue - Dates: British Association for Psychopharmacology Summer Meeting, Imperial College London, London, United Kingdom, 2018-07-22 - 2018-07-25

Identifiers

Local EPrints ID: 468924
URI: http://eprints.soton.ac.uk/id/eprint/468924
PURE UUID: 874e9bba-ee53-4e2b-ad82-17d05c3c7d80
ORCID for David Baldwin: ORCID iD orcid.org/0000-0003-3343-0907
ORCID for Ruihua Hou: ORCID iD orcid.org/0000-0001-6127-1478

Catalogue record

Date deposited: 01 Sep 2022 16:48
Last modified: 17 Mar 2024 03:10

Export record

Contributors

Author: M Hou
Author: David Baldwin ORCID iD
Author: Ruihua Hou ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×